TCL Archive Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say. June 24, 2005
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources October 24, 1980
TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees January 6, 1984
